Aliquots
-
Long live the therapeutic stem cells
Enhancing stem cell survival is key to improving cell-based therapies for regenerative medicine, and a new drug could help. Read MoreMay 17, 2012
-
New clue to ADHD
A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD. Read MoreMay 15, 2012
-
Perfect timing for sensory processing
Identification of brain regions involved in processing sights and sounds may offer insights into disorders like autism and dyslexia. Read MoreMay 11, 2012
-
Probing epilepsy’s molecular sparks
Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies. Read MoreMay 10, 2012
-
Early stomach troubles augur anxiety
Children with stomach troubles grow up to be anxious adolescents and young adults, according to a recent study. Read MoreMay 2, 2012
-
Better blood pressure-reducing drugs?
A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome. Read MoreApr 30, 2012
-
Dengue antibodies give vaccine leads
New information may help speed development of a vaccine or treatment for dengue fever. Read MoreApr 27, 2012
-
New drug mutes more melanomas
An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies. Read MoreApr 26, 2012
-
Neuronal clues to cholesterol-defect disorder
Antioxidants may be a beneficial treatment for an inherited genetic disorder. Read MoreApr 20, 2012
-
Pathways to delirium in the ICU
Study suggests that the “kynurenine” biochemical pathway could be a target for reducing delirium and coma in critically ill patients. Read MoreApr 17, 2012
-
Wilms’ tumors differ in developing nations
In addition to limited health care resources, biological factors may play a role in the poor survival of children with a common kidney cancer in developing nations. Read MoreApr 13, 2012
-
Targeting post-transplant diabetes
Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes. Read MoreApr 12, 2012
-
Factor sensitizes cancer to radiation
Measuring levels of an enzyme in head and neck tumors may indicate how the tumor will respond to radiation therapy. Read MoreApr 6, 2012
-
New tool hooks heart failure drugs
A new screening tool – using glowing fish embryos – could identify therapeutics for myocardial hypertrophy and heart failure. Read MoreApr 6, 2012
-
Plant compound quells inflammation
Berberine, an herbal remedy for diarrhea and intestinal parasites, may be an effective treatment for gastrointestinal inflammatory diseases. Read MoreApr 6, 2012
-
Gut germs govern growth
Treating H. pylori infection in children may help their growth rebound, a recent study suggests. Read MoreApr 6, 2012
-
Smoking stokes cells’ cancer capacity
Cellular pathways altered by chronic exposure to cigarette smoke may reveal new biomarkers to assess smoking-induced lung cancer risk. Read MoreMar 23, 2012
-
Obesity turns “good” cholesterol bad
Studies offer new insights into how obesity impairs the function of HDL, the “good” cholesterol. Read MoreMar 21, 2012
-
iPOND method goes fishing for proteins
A new tool will allow researchers to identify proteins involved in DNA replication and damage repair, processes that go awry in cancer. Read MoreMar 19, 2012
-
Colon cancer’s cellular crossroads
New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease. Read MoreMar 16, 2012